Does ESKETAMINE Cause Product dose omission issue? 635 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 635 reports of Product dose omission issue have been filed in association with ESKETAMINE (Spravato). This represents 4.2% of all adverse event reports for ESKETAMINE.
635
Reports of Product dose omission issue with ESKETAMINE
4.2%
of all ESKETAMINE reports
13
Deaths
68
Hospitalizations
How Dangerous Is Product dose omission issue From ESKETAMINE?
Of the 635 reports, 13 (2.0%) resulted in death, 68 (10.7%) required hospitalization, and 9 (1.4%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESKETAMINE. However, 635 reports have been filed with the FAERS database.
What Other Side Effects Does ESKETAMINE Cause?
Dissociation (3,103)
Sedation (2,244)
Suicidal ideation (1,254)
Drug ineffective (1,005)
Nausea (807)
Depression (800)
Anxiety (659)
Hospitalisation (657)
Hypertension (605)
Vomiting (600)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ESKETAMINE Alternatives Have Lower Product dose omission issue Risk?
ESKETAMINE vs ESLICARBAZEPINE
ESKETAMINE vs ESMOLOL
ESKETAMINE vs ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\NAPROXEN